Who owns CELLECTAR BIOSCIENCES INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Cellectar Biosciences with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Cellectar Biosciences stock

Who bought or sold CELLECTAR BIOSCIENCES INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Bleichroeder 100k $295k 0% Dec 2025
 View chart
Vanguard Group 89k $263k 37% Dec 2025
 View chart
DRW Holdings 45k $133k 114% Dec 2025
 View chart
Geode Capital Management 29k $85k 15% Dec 2025
 View chart
Sequoia Financial Advisors 25k $75k 135% Dec 2025
 View chart
Citadel Advisors 19k $104k 100% Sep 2025
 View chart
Warberg Asset Management 14k $41k 100% Dec 2025
 View chart
XTX Topco 12k $36k 100% Dec 2025
 View chart
Susquehanna International 12k $36k 100% Dec 2025
 View chart
Riverview Capital Advisers 10k $50k 0% Dec 2025
 View chart
BlackRock 4.7k $14k 0% Dec 2025
 View chart
UBS Group 2.6k $7.7k 186% Dec 2025
 View chart
Tower Research Capital 1.8k $5.4k 68% Dec 2025
 View chart
TD Waterhouse Canada 63.00 $180.999000 100% Dec 2025
 View chart
SBI Securities 11.00 $32.000100 0% Dec 2025
 View chart
Advisor Group Holdings 7.00 $19.000100 -70% Dec 2025
 View chart
Jones Financial Companies, L.L 3.00 $9.000000 0% Dec 2025
 View chart
Us Bancorp 3.00 $9.000000 0% Dec 2025
 View chart
Danske Bank A/s 2.00 $6.000000 0% Dec 2025
 View chart

Who sold out of Cellectar Biosciences?

Fund or Company Name Date Sold Shares Held Valued At
Renaissance Technologies Sep 2025 25k $139k
Dimensional Fund Advisors Sep 2025 13k $73k
Group One Trading Sep 2025 23.00 $129.000100